A Hemodialysis Patient With Secondary Hemochromatosis and Miliary Tuberculosis

dc.contributor.authorDogukan, Ayhan
dc.contributor.authorOzalp, Goksel
dc.contributor.authorOzercan, Ibrahim
dc.contributor.authorAygen, Bilge
dc.contributor.authorGunal, Ali Ihsan
dc.contributor.authorBahcecioglu, Ibrahim Halil
dc.date.accessioned2026-08-12T17:01:40Z
dc.date.issued2005
dc.departmentFırat Üniversitesi
dc.description.abstractWhile treatment with intravenous iron is essential for iron deficiency in hemodialysis patients, there is also evidence that links iron and iron overload with an increased risk of infection. In this article, we present a hemodialysis patient who develops secondary hemochromatosis and subsequent miliary tuberculosis.
dc.identifier.endpage92
dc.identifier.issn1300-7718
dc.identifier.issue2
dc.identifier.startpage90
dc.identifier.urihttps://hdl.handle.net/11508/47830
dc.identifier.volume14
dc.identifier.wosWOS:000217136000009
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isotr
dc.publisherTurk Nefroloji Diyaliz Transplantasyon Dergisi
dc.relation.ispartofTurkish Nephrology Dialysis and Transplantation Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjecthemochromatosis
dc.subjecttuberculosis
dc.subjecthemodialysis
dc.titleA Hemodialysis Patient With Secondary Hemochromatosis and Miliary Tuberculosis
dc.typeArticle

Dosyalar